🖼
Extended Data Fig. 8: CONSORT diagram for case selection for first-line CDK4/6i + ET outcomes stratifi...
active
paper figure
Created: 2026-04-27T04:55:50
By: paper_figures_pipeline
Quality:
50%
🔗 External
ID: paper-fig-51fd0021-0cc8-4669-b21b-53650e
Extended Data Fig. 8Figure 11
CONSORT diagram for case selection for first-line CDK4/6i + ET outcomes stratified by allele-specific copy number of RB1. ASCN analysis was performed on tumor samples collected prior to initiation of first-line CDK4/6i + ET. Samples were excluded (n = 158) for technical reasons including low purity or paucity of heterozygous SNPs in the region of interest. The CONSORT diagram describes the clinical outcomes analysis on the 547 samples remaining, as well as the matched pairs analysis on the 405 samples with corresponding post progression biopsies.
▸Metadata
| doi | 10.1038/s41586-026-10197-0 |
| pmcid | PMC13083263 |
| _origin | {'url': 'https://www.ebi.ac.uk/europepmc/articles/PMC13083263/bin/41586_2026_10197_Fig12_ESM.jpg', 'type': 'external', 'tracked_at': '2026-04-27T11:55:50.103484'} |
| caption | CONSORT diagram for case selection for first-line CDK4/6i + ET outcomes stratified by allele-specific copy number of RB1. ASCN analysis was performed on tumor samples collected prior to initiation of |
| paper_id | 51fd0021-0cc8-4669-b21b-53650ed26d0f |
| image_url | https://www.ebi.ac.uk/europepmc/articles/PMC13083263/bin/41586_2026_10197_Fig12_ESM.jpg |
| image_path | |
| description | |
| figure_label | Extended Data Fig. 8 |
| figure_number | 11 |
| _schema_version | 1 |
| source_strategy | pmc_api |
| entities_mentioned |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.